Balchem Corporation
Balchem Corporation develops specialty performance ingredients and products globally. The company operates three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition segment supplies ingredients for food and beverage industries. The Animal Nutrition segment provides microencapsulated products for animal health and milk production. The Specialty Products segment distributes chemicals for sterilization and fumigation. Balchem sells its products through a sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in New Jersey.
Overview
Strengths
- Shows the financial signature of a durable competitive advantage (economic moat): returns well above its cost of capital, an asset-light, cash-generative model and operating margins that held up every year.
- Creates economic value: ROIC of 15.1% against a cost of capital (WACC) of 7.5%, a spread of 7.6 percentage points.
- Asset-light, cash-generative model: capital expenditure takes only 4.4% of revenue and free cash flow was positive in each of the last 6 years.
- Resilient profitability: operating margin stayed between 15% and 20% in each of the last 6 years.
- Consistent growth: revenue has compounded at 8.1% a year over 5 years, rising in 4 of them.
- Conservative leverage: net debt is only 0.4x EBITDA.
Weaknesses
- Our discounted cash flow target price (67.87 USD) is 61% below the current price.
- Valued at a premium to its Specialty Chemicals peers: P/FCF 32.3x vs. a median of 22.5x and EV/EBITDA 22.4x vs. a median of 15.3x.
Key Financial Data